Eczema on Face: Causes, Gentle Treatments, and Skincare Tips

Atopic dermatitis on the face in adults usually appears as dry, itchy, scaly patches on the eyelids, around the eyes and mouth, on the lips, and along the neck, and it is treated with a stripped-back fragrance-free skincare routine plus short courses of low-potency steroids or steroid-free creams such as tacrolimus. Facial skin has a thinner, leakier barrier than skin on the trunk, and eyelid skin is only about 0.5 mm thick, so it absorbs medicines readily and needs gentler treatment than eczema elsewhere on the body [1][4].

What Does Atopic Dermatitis on the Face Look Like in Adults?

Atopic dermatitis (AD), the most common form of eczema, follows a different map in adults than in babies. Infants tend to get it on the cheeks and chin, while adults most often see it on the eyelids, the skin around the eyes, the forehead, the area around the mouth, the lips, and the sides of the neck [3]. Some adults have a pattern dermatologists call head and neck dermatitis, where the face, neck and upper chest flare together.

Adult facial AD looks like dry, rough, scaly patches that itch, often worst at night. In lighter skin the patches look pink or red; in brown and Black skin they often look dark brown, purple or ashy gray, and they can leave lighter or darker marks (post-inflammatory pigment change) after they settle. Years of rubbing thicken the skin (lichenification), and some adults notice extra creases under the lower lids (Dennie-Morgan folds) or thinning at the outer edge of the eyebrows from scratching.

Why does facial eczema start or come back in adulthood?

Many adults with facial AD had eczema as children that faded and then returned. Others develop it for the first time in adulthood, which dermatologists call adult-onset atopic dermatitis. Common reasons for a new or returning facial flare include a new skincare or hair product, a move to a drier climate, a stressful period, frequent mask wearing, hormonal shifts, and occupational exposures to cleaning agents or solvents.

A new rash on the adult face is not always atopic: contact dermatitis, seborrheic dermatitis, rosacea, perioral dermatitis and facial psoriasis can look similar, and each needs different treatment.

Why the Face Is So Prone to Eczema

Facial skin is structurally different from skin elsewhere on the body, and those differences make it uniquely vulnerable to eczema. The epidermis on the face (particularly around the eyelids) is significantly thinner than on the arms, legs, or trunk. This thinner barrier allows allergens, irritants, and microbes to penetrate more easily while also losing moisture at a higher rate [1].

The face is also the most environmentally exposed part of the body. Wind, cold air, UV radiation, and pollution assault facial skin daily. On top of that, most people apply multiple products to their face (cleansers, moisturizers, sunscreen, makeup) each providing an opportunity for irritant or allergic reactions [2].

Blood flow to the face is higher than to most other skin sites, which means inflammatory mediators arrive quickly and in large numbers. This is why facial eczema can flare rapidly and appear intensely red.

Types of Eczema That Affect the Face

Atopic Dermatitis on the Face

Atopic dermatitis (AD) commonly involves the face, particularly in infants and young children. In babies, the cheeks, forehead, and chin are often the first sites of eczema, reflecting the areas of greatest environmental contact (drool, food, carpet) [3].

In adults, AD on the face tends to affect the eyelids, periorbital skin (around the eyes), lips, and the neck/jawline area. Eyelid eczema is especially problematic because the skin there is the thinnest on the body (approximately 0.5 mm) and is exquisitely sensitive to both irritants and the side effects of treatment [4].

Signs of facial AD include dry, scaly, erythematous patches; lichenification (skin thickening from chronic rubbing); Dennie-Morgan folds (extra creases under the eyes); and perioral pallor. Chronic eyelid eczema can lead to anterior blepharitis and, over time, changes to the periorbital skin pigmentation.

Allergic Contact Dermatitis on the Face

The face is a common site for allergic contact dermatitis (ACD) because it receives so many product applications. The most frequent culprits include [5]:

• Fragrances: Found in moisturizers, cleansers, toners, and cosmetics. The number one cause of cosmetic ACD.
• Preservatives: Methylisothiazolinone (MI), formaldehyde-releasing preservatives, and parabens.
• Hair dye chemicals: Para-phenylenediamine (PPD) in hair dye can cause severe facial and scalp dermatitis.
• Nickel: From eyeglass frames, eyelash curlers, and mobile phones held against the face.
• Sunscreen ingredients: Chemical UV filters like oxybenzone and avobenzone. Mineral sunscreens (zinc oxide, titanium dioxide) are far less likely to cause reactions.
• Nail polish: Tosylamide/formaldehyde resin in nail polish transferred to the face by touching. The nails themselves are unaffected.

A key clue to contact dermatitis: the pattern matches the exposure. Eyelid dermatitis from nail polish, linear streaks from hair products dripping during rinsing, or dermatitis limited to where eyeglass frames sit all point to ACD.

Seborrheic Dermatitis

Seborrheic dermatitis (SD) is a distinct condition from atopic eczema, driven by the skin’s inflammatory response to Malassezia yeast, which thrives in sebaceous (oil-rich) areas. On the face, it characteristically affects the nasolabial folds, eyebrows, glabella (between the brows), hairline, and ears [6].

The appearance differs from AD: seborrheic dermatitis produces greasy, yellowish scales on a pink base rather than the dry, rough patches of atopic dermatitis. It tends to be less itchy than AD and responds to antifungal treatments (ketoconazole cream, zinc pyrithione) rather than standard eczema therapy.

How do you tell facial eczema from rosacea, perioral dermatitis and psoriasis?

Location, texture and itch separate the common facial rashes. A dermatologist confirms the diagnosis by examination and, for suspected contact allergy, patch testing. For a closer look at the scaly overlap between the two most confused conditions, see the guide to psoriasis versus eczema.

Common Triggers for Facial Eczema

• Weather changes: Cold, dry winter air is the most common trigger. Wind exposure and sudden temperature shifts also provoke flares [7].
• Skincare products: Fragranced products, alcohol-based toners, retinoids, and alpha-hydroxy acids (glycolic acid, lactic acid) can irritate compromised facial skin.
• Water: Hard water with high mineral content can be irritating. Excessive face washing strips natural oils.
• Stress: Emotional stress triggers facial flushing and increases inflammatory mediator release in the skin.
• Airborne allergens: Dust mites, pollen, and pet dander can trigger facial eczema through both airborne contact and the itch-rub-scratch cycle.
• Food contact: In young children, saliva and food residue around the mouth triggers perioral eczema. Citrus and tomato are common culprits.

Adults often find that two or three triggers stack up before a facial flare, such as dry indoor heat, a stressful month and a new face product. The overview of common eczema triggers covers the full list beyond the face.

Treating Eczema on the Face

Treatment for adult facial atopic dermatitis has two layers: a daily skincare routine that repairs the barrier, and an anti-inflammatory medicine used during flares or, for some people, a couple of days a week to keep flares away. According to the American Academy of Dermatology guidelines for adults (Sidbury et al., 2023), moisturizers, topical corticosteroids, topical calcineurin inhibitors, the PDE4 inhibitor crisaborole and the JAK inhibitor cream ruxolitinib are all recommended options [14]. The general eczema treatment guide covers the same medicines for the rest of the body.

The Skincare Foundation

Before any medication, the daily skincare routine must be right. For facial eczema, this means stripping the routine down to essentials [8]:

Cleansing:

• Use a gentle, fragrance-free, soap-free cleanser; look for a short ingredient list and the words soap-free and fragrance-free on the label
• Wash with lukewarm water, not hot
• Cleanse once daily (evening) if possible. In the morning, rinsing with plain water is sufficient for most people
• Pat dry gently with a soft towel; never rub

Moisturizing:

• Apply a fragrance-free, ceramide-containing moisturizer within 3 minutes of washing while skin is still damp
• Creams and ointments are more effective than lotions. For daytime use, a cream formulation is cosmetically acceptable; at night, an ointment or heavier cream provides better barrier repair.
• Reapply as needed throughout the day, especially in dry environments

Sun protection:

• Use a mineral sunscreen (zinc oxide or titanium dioxide) rather than chemical sunscreens, which are more likely to irritate sensitive skin [2]
• SPF 30 or higher, applied daily
• Look for fragrance-free mineral sunscreens labeled for sensitive skin, and test a new one on a small patch first

Choosing a moisturizer is the step most people get wrong, mainly by picking a fragranced lotion. The guide to choosing an eczema cream explains the difference between creams, ointments and barrier-repair formulas in more detail.

Topical Anti-Inflammatory Treatments

Facial skin requires careful medication selection because it is thin and highly absorptive, making it more susceptible to steroid side effects (atrophy, telangiectasia, perioral dermatitis).

Low-potency topical corticosteroids (short-term use):

• Hydrocortisone 1-2.5% ointment or cream: suitable for brief courses (1-2 weeks) on the face
• Desonide 0.05% (DesOwen): a low-potency prescription option suitable for facial use
• Avoid mid-to-high potency steroids on the face. Prolonged use of potent steroids on facial skin can cause irreversible skin thinning and telangiectasia within weeks [9]

Topical calcineurin inhibitors (preferred for maintenance):

• Tacrolimus 0.03% or 0.1% ointment (Protopic): in adults, tacrolimus 0.1% worked as well as the medium-potency steroid hydrocortisone butyrate in a head-to-head trial, without causing the skin atrophy that steroids can. This makes it the preferred long-term option for facial and eyelid eczema [10].
• Pimecrolimus 1% cream (Elidel): slightly less potent than tacrolimus but cosmetically elegant and well suited for mild-to-moderate facial eczema.
• Both may cause burning or stinging on initial application, which typically resolves within a few days of regular use.
• Both carry an FDA boxed warning, added in 2006, about a theoretical cancer risk based on animal studies and rare case reports; the warning is why they are labeled as second-line options, and dermatologists weigh it against the steroid side effects they avoid.

Topical PDE4 inhibitor:

• Crisaborole 2% ointment (Eucrisa): a non-steroidal option approved for mild-to-moderate atopic dermatitis and suitable for use on the face. Less effective than calcineurin inhibitors for moderate disease but provides another steroid-free choice [11].

Topical JAK inhibitor:

• Ruxolitinib 1.5% cream (Opzelura): approved for mild-to-moderate atopic dermatitis and usable on the face. Provides rapid itch relief (often within 1-2 days) and has anti-inflammatory efficacy comparable to medium-potency steroids without atrophy risk [12]. It carries the same boxed warning as oral JAK inhibitors, so it is prescribed for short, limited-area use.

Newer steroid-free creams:

• Roflumilast 0.15% cream, a second PDE4 inhibitor, and tapinarof 1% cream, an aryl hydrocarbon receptor agonist, were both approved by the FDA for atopic dermatitis in 2024. Facial experience with both is shorter than with tacrolimus.

Which facial eczema treatments are used for adults?

The table compares the topical options above; how long each is used depends on the prescriber and the area treated.

Eyelid Eczema: Special Considerations

The eyelids demand extra caution. The skin is extremely thin, highly vascular, and adjacent to the eyes themselves [4]:

• Tacrolimus 0.03% ointment is the preferred treatment for eyelid eczema. It can be applied close to the lid margin without the atrophy risk of steroids.
• If a topical steroid is needed for acute flares, use hydrocortisone 1% for no more than 5-7 days.
• Never use mid-to-high potency steroids on the eyelids. Even brief courses can cause elevated intraocular pressure and cataracts.
• Avoid contact lens solutions and eye makeup removers with preservatives (benzalkonium chloride is a common irritant).
• If eyelid eczema is persistent and unilateral, consider allergic contact dermatitis and pursue patch testing.

Lip Eczema (Eczematous Cheilitis)

Eczema on and around the lips (eczematous cheilitis) is common in atopic patients and is often worsened by habitual lip licking, which deposits saliva enzymes that damage the skin barrier [13]. Management includes:

• Breaking the lip-licking habit (a barrier ointment like plain petroleum jelly helps)
• Avoiding flavored or fragranced lip products
• Using a bland, fragrance-free petrolatum-based emollient multiple times daily
• Short courses of low-potency topical steroids or tacrolimus for active inflammation
• Considering contact allergy to toothpaste ingredients (cinnamal, sodium lauryl sulfate) if cheilitis is persistent

When does facial eczema need treatment beyond creams?

Adults whose facial eczema stays moderate to severe despite good skincare and topical medicines may be offered systemic treatment by a dermatologist. Options include the injectable biologics dupilumab, tralokinumab, lebrikizumab and nemolizumab, the oral JAK inhibitors upadacitinib and abrocitinib, and narrowband UVB phototherapy. In the SOLO 1 and SOLO 2 trials (Simpson et al., 2016), dupilumab improved moderate-to-severe atopic dermatitis in adults compared with placebo [15].

The face can behave differently on these medicines. A minority of people on dupilumab develop new redness on the face and neck or eye irritation (conjunctivitis), which a dermatologist assesses separately rather than treating as ordinary eczema. The full range of steroid, biologic and natural approaches is laid out in the eczema treatment overview.

Skincare Ingredients to Avoid with Facial Eczema

• Fragrance (including “natural” fragrance and essential oils): the number one cause of cosmetic contact dermatitis [5]
• Alcohol (denatured alcohol, SD alcohol): strips the lipid barrier and stings compromised skin
• Retinoids (retinol, tretinoin): too irritating during active flares. Can be reintroduced cautiously during remission.
• Alpha-hydroxy acids (glycolic acid, lactic acid): exfoliating acids disrupt an already compromised barrier
• Sodium lauryl sulfate (SLS): a harsh surfactant found in many cleansers and shampoos
• Witch hazel: despite its reputation as “natural” and soothing, it can be irritating to eczema-prone skin

Makeup and Facial Eczema

Many patients worry about wearing makeup during flares, but makeup is generally safe if you follow a few guidelines [2]:

• Choose fragrance-free, non-comedogenic, hypoallergenic products with short ingredient lists
• Apply moisturizer first as a base layer, let it absorb for a few minutes, then apply makeup
• Mineral powder foundations are often better tolerated than liquid foundations because they contain fewer preservatives and irritants
• Remove makeup gently with a fragrance-free micellar water or a gentle oil-based cleanser. Avoid makeup wipes, which require rubbing and contain preservatives.
• Replace makeup products regularly (mascara every 3 months, foundations every 6-12 months) to prevent bacterial contamination
• If a new product causes irritation, stop using it immediately. Test new products on a small patch of skin on the inner forearm for 3-5 days before applying to the face.

How Long Does Facial Eczema Take to Clear?

A mild facial flare treated with gentle skincare and a short course of low-potency steroid usually settles within one to two weeks, which is why the dermatology referral threshold below is set at two weeks. Ruxolitinib cream often eases itch within one to two days, and the initial stinging from tacrolimus or pimecrolimus typically fades within a few days of regular use [10][12].

Atopic dermatitis is a chronic, relapsing condition, so clearing a flare is not the same as being finished with it. The European consensus guidelines (Wollenberg et al., 2018) describe proactive treatment, in which a calcineurin inhibitor is applied twice a week to skin that has cleared, as a way to reduce how often flares return [8]. Pigment changes left behind in darker skin can take months to fade even after the inflammation has gone.

When to See a Dermatologist

• Facial eczema that does not respond to gentle skincare and OTC hydrocortisone within 2 weeks
• Eyelid eczema that is persistent or recurrent
• Suspected allergic contact dermatitis (asymmetric or patterned distribution, new onset after product change)
• Signs of secondary infection: crusting, weeping, increased pain, or spreading redness
• Need for patch testing to identify triggering allergens
• Facial eczema significantly affecting quality of life, sleep, or social functioning

Board-certified dermatologists diagnose and treat facial eczema, and many perform patch testing; some allergists and immunologists do as well. Patch testing uses the allergen series tracked by the North American Contact Dermatitis Group, which is how fragrance and preservatives were identified as leading cosmetic allergens [5]. An ophthalmologist should be involved when eyelid eczema comes with eye pain, blurred vision, or a need for steroid drops.

Where Can Adults Find Care for Facial Eczema?

Most adults start with a primary care clinician or a dermatologist, who handle the prescription creams, patch testing and systemic medicines described above. Some people with long-running eczema also visit integrative or functional medicine clinics for help with triggers, diet and stress; evidence for most of those services in atopic dermatitis is thin, and they are usually cash pay.

The national list of clinics offering eczema treatment shows practices by state and city. Listing order on Regenerated.com is not paid ranking, Featured slots are clearly labeled and capped, and Verified means a clinic completed credential checks, not that it paid more. Regenerated.com is free for patients, and inclusion in the directory is not an endorsement. The guide to Featured, Verified and organic listings explains each label.

Frequently asked questions

What does atopic dermatitis on the face look like in adults?

Atopic dermatitis on the adult face looks like dry, rough, itchy patches, most often on the eyelids, around the eyes and mouth, on the lips and along the neck. The patches look pink or red on lighter skin and brown, purple or gray on darker skin. Long-standing patches thicken from rubbing, and some adults develop extra creases under the lower eyelids. Greasy yellow scale in the eyebrows and nose folds points to seborrheic dermatitis instead.

What is the most effective treatment for eczema on the face?

The most effective approach for facial eczema combines a fragrance-free cleanser and moisturizer with a medicine matched to the area. Short courses of low-potency steroids such as hydrocortisone calm flares, and tacrolimus or pimecrolimus suit longer use and the eyelids because they do not thin the skin. Crisaborole and ruxolitinib cream are other steroid-free options. Adults with moderate-to-severe disease may be offered biologics such as dupilumab by a dermatologist.

Can I use hydrocortisone cream on my face?

Yes, hydrocortisone 1% to 2.5% is a low-potency steroid that can be used on the face for brief courses of one to two weeks, and for no more than five to seven days on the eyelids. Longer use on facial skin risks thinning, visible blood vessels and perioral dermatitis. Stronger steroids should not go on the face unless a dermatologist directs it. If a flare is not settling after two weeks, a dermatologist visit is the next step.

Why did I suddenly get eczema on my face as an adult?

Adult facial eczema often appears after a change that strains the skin barrier: a new cosmetic or hair product, a move to a dry climate, winter heating, stress, or frequent mask wearing. Some adults had childhood eczema that returned, while others develop adult-onset atopic dermatitis. A sudden rash that follows the outline of a product, glasses frame or hair dye is more likely allergic contact dermatitis, which patch testing can confirm.

How long does eczema on the face take to heal?

A mild flare of facial eczema usually calms within one to two weeks of gentle skincare and a short course of low-potency steroid or a steroid-free cream. Itch from ruxolitinib cream often eases within one to two days. Because atopic dermatitis relapses, many dermatologists suggest twice-weekly tacrolimus on cleared skin to keep flares away. Dark or light marks left in skin of color can take several months to fade.

Is it eczema, rosacea or seborrheic dermatitis on my face?

Eczema on the face is itchy, dry and scaly and favors the eyelids, mouth area and neck. Rosacea causes flushing, persistent central redness and visible vessels, and tends to burn rather than itch. Seborrheic dermatitis shows greasy, yellowish scale in the eyebrows, nose folds and hairline and responds to antifungal treatment. The three need different treatments, so a dermatologist should confirm which one is present before long-term treatment starts.

Related Reading

• Eczema: Complete Guide
• Eczema Treatment: Steroids, Biologics, Natural Options
• Eczema Cream: How to Choose the Right One

Sources

1. Tagami H. Location-related differences in structure and function of the stratum corneum with special emphasis on those of the facial skin. Int J Cosmet Sci. 2008;30(6):413-434. doi:10.1111/j.1468-2494.2008.00459.x ↩
2. Zirwas MJ, Moennich J. Moisturizer allergy: diagnosis and management. J Clin Aesthet Dermatol. 2008;1(4):38-44. ↩
3. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-351. doi:10.1016/j.jaad.2013.10.010 ↩
4. Bielory L, Katelaris CH, Lightman S, et al. Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders. MedGenMed. 2007;9(3):35. ↩
5. Warshaw EM, Maibach HI, Taylor JS, et al. North American Contact Dermatitis Group patch test results: 2011-2012. Dermatitis. 2015;26(1):49-59. doi:10.1097/DER.0000000000000097 ↩
6. Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015;3(2):10. doi:10.13188/2373-1044.1000019 ↩
7. Engebretsen KA, Johansen JD, Kezic S, et al. The effect of environmental humidity and temperature on skin barrier function and dermatitis. J Eur Acad Dermatol Venereol. 2016;30(2):223-249. doi:10.1111/jdv.13301 ↩
8. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657-682. doi:10.1111/jdv.14891 ↩
9. Hengge UR, Ruzicka T, Schwartz RA, et al. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1-15. doi:10.1016/j.jaad.2005.01.010 ↩
10. Reitamo S, Rustin M, Ruzicka T, et al. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol. 2002;109(3):547-555. doi:10.1067/mai.2002.121832 ↩
11. Paller AS, Tom WL, Lebwohl MG, et al. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J Am Acad Dermatol. 2016;75(3):494-503. doi:10.1016/j.jaad.2016.05.046 ↩
12. Papp K, Szepietowski JC, Kircik L, et al. Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: results from 2 phase 3, randomized, double-blind studies. J Am Acad Dermatol. 2021;85(4):863-872. doi:10.1016/j.jaad.2021.04.085 ↩
13. Lugovic-Mihic L, Pilipovic K, Crnaric I, et al. Differential diagnosis of cheilitis. Acta Clin Croat. 2018;57(2):342-351. doi:10.20471/acc.2018.57.02.16 ↩
14. Sidbury R, Alikhan A, Bercovitch L, et al. Guidelines of care for the management of atopic dermatitis in adults with topical therapies. J Am Acad Dermatol. 2023;89(1):e1-e20. doi:10.1016/j.jaad.2022.12.029 ↩
15. Simpson EL, Bieber T, Guttman-Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375(24):2335-2348. doi:10.1056/NEJMoa1610020 ↩